The store will not work correctly when cookies are disabled.
5-[2-(dimethylamino)ethyl]-11,12-dihydrobenzo[c][1]benzazocin-6-one
ID: ALA4744893
PubChem CID: 162647537
Max Phase: Preclinical
Molecular Formula: C19H22N2O
Molecular Weight: 294.40
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: CN(C)CCN1C(=O)c2ccccc2CCc2ccccc21
Standard InChI: InChI=1S/C19H22N2O/c1-20(2)13-14-21-18-10-6-4-8-16(18)12-11-15-7-3-5-9-17(15)19(21)22/h3-10H,11-14H2,1-2H3
Standard InChI Key: BTCYIPDQTUQALX-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
21.4313 -2.7900 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4301 -3.6095 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1382 -4.0185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1364 -2.3811 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.2541 -4.1722 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4355 -4.1790 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.8518 -3.6050 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8450 -2.7864 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4190 -2.2027 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.2377 -2.1959 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8197 -2.7694 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8282 -3.5885 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5407 -3.9890 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2452 -3.5714 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2328 -2.7492 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5197 -2.3524 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.5732 -4.9246 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.0217 -4.8825 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2045 -4.8758 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7902 -5.5802 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.9730 -5.5735 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1930 -6.2912 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 7 2 0
8 4 2 0
4 1 1 0
12 5 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
5 17 2 0
6 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
20 22 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 294.40 | Molecular Weight (Monoisotopic): 294.1732 | AlogP: 2.99 | #Rotatable Bonds: 3 |
Polar Surface Area: 23.55 | Molecular Species: NEUTRAL | HBA: 2 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 8.23 | CX LogP: 3.51 | CX LogD: 2.62 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.87 | Np Likeness Score: -0.88 |
References
1. Bieszczad B,Siwek A,Wilczek M,Trzybiński D,Woźniak K,Satała G,Bojarski AJ,Mieczkowski A. (2020) Synthesis, crystal structure and biological activity of novel analogues of tricyclic drugs., 30 (21.0): [PMID:32798652] [10.1016/j.bmcl.2020.127493] |